# Diagnostic value of a novel automated simultaneous amplification and testing method in pulmonary tuberculosis and extrapulmonary tuberculosis

**Authors:** Xichao Ou, Peilei Hu, Xundi Bao, Zhou Liu, Chong Teng, Jingwei Guo, Dongfang Xu, Yue Li, Bing Zhao, Ruida Xing, Hui Xia, Ling Ma, Yang Zhou, Yang Zheng, Yuanyuan Song, Shengfen Wang, Yanlin Zhao, Yunhong Tan, Huiwen Zheng

PMC · DOI: 10.3389/fmicb.2025.1590635 · Frontiers in Microbiology · 2025-05-14

## TL;DR

This study compares a new automated test for tuberculosis with an existing method and finds it effective, especially for certain types of samples.

## Contribution

The study introduces and evaluates the diagnostic accuracy of a novel automated simultaneous amplification and testing method for tuberculosis.

## Key findings

- AutoSAT showed equal sensitivity to Xpert for bacteriologically confirmed pulmonary tuberculosis.
- AutoSAT outperformed Xpert in sensitivity for paucibacillary extrapulmonary tuberculosis, especially in pleural fluid.
- AutoSAT demonstrated high specificity for both pulmonary and extrapulmonary tuberculosis.

## Abstract

To evaluate the clinical diagnostic ability of automated simultaneous amplification and testing (AutoSAT) method in suspected pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) by comparing with Xpert MTB/RIF (Xpert) method against the composite reference standard.

Patients with suspected PTB or EPTB were enrolled consecutively from two provincial tuberculosis designated hospitals between August 2022 and December 2023. Clinical specimens were collected for routine clinical tests and AutoSAT.

The 297 patients including 90 PTB suspects and 207 EPTB suspects were eligible for final analysis. Among the 63 confirmed PTB, the sensitivity of Xpert was significantly higher than that of AutoSAT (30.16% vs. 28.57%, p < 0.001). Of the 18 bacteriologically confirmed PTB, equal sensitivity (94.44%) was observed between Xpert and AutoSAT. The higher specificity of AutoSAT than Xpert (100% vs. 96.30%, p = 0.803) was observed among PTB. The higher sensitivity of AutoSAT than Xpert was observed among confirmed EPTB (22.07% vs. 18.62%, p < 0.001) and bacteriologically confirmed EPTB patients (92.31% vs. 84.62%, p = 0.53), but the specificity (100%) was equal. And AutoSAT yielded higher sensitivity on pleural fluid (14.91% vs. 9.65%, p = 0.276). The same specificities (100%) were observed on different types of specimens.

AutoSAT is an accurate, sensitive and rapid method for the detection of Mycobacterium tuberculosis in both PTB and EPTB patients. AutoSAT is highly effective in bacteriologically confirmed PTB, and outperforms Xpert in paucibacillary EPTB patients, especially for pleural fluid specimen detection.

## Linked entities

- **Diseases:** tuberculosis (MONDO:0018076), pulmonary tuberculosis (MONDO:0006052), extrapulmonary tuberculosis (MONDO:0000368)
- **Species:** Mycobacterium tuberculosis (taxon 1773)

## Full-text entities

- **Diseases:** PTB (MESH:D014397), EPTB (MESH:D000092225), tuberculosis (MESH:D014376)
- **Chemicals:** Xpert MTB (-)
- **Species:** Mycobacterium tuberculosis (species) [taxon 1773], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12131008/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12131008/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12131008/full.md

---
Source: https://tomesphere.com/paper/PMC12131008